These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 10371653)
1. Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission. Piepponen TP; Honkanen A; Kivastik T; Zharkovsky A; Turtia A; Mikkola JA; Ahtee L Pharmacol Biochem Behav; 1999 Jun; 63(2):245-52. PubMed ID: 10371653 [TBL] [Abstract][Full Text] [Related]
2. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat. Borg PJ; Taylor DA Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296 [TBL] [Abstract][Full Text] [Related]
3. Effects of selective opioid receptor antagonists on morphine-induced changes in striatal and limbic dopamine metabolism. Piepponen TP; Ahtee L Pharmacol Toxicol; 1995 Sep; 77(3):204-8. PubMed ID: 8884884 [TBL] [Abstract][Full Text] [Related]
4. Effects of repeated morphine on cerebral dopamine release and metabolism in AA and ANA rats. Mikkola JA; Honkanen A; Piepponen TP; Kiianmaa K; Ahtee L Pharmacol Biochem Behav; 2000 Dec; 67(4):783-91. PubMed ID: 11166069 [TBL] [Abstract][Full Text] [Related]
5. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment. Honkanen A; Piepponen TP; Ahtee L Neurosci Lett; 1994 Oct; 180(2):119-22. PubMed ID: 7700562 [TBL] [Abstract][Full Text] [Related]
6. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats. Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540 [TBL] [Abstract][Full Text] [Related]
7. Effect of morphine on striatal dopamine metabolism and ascorbic and uric acid release in freely moving rats. Enrico P; Esposito G; Mura MA; Fresu L; De Natale G; Miele E; Desole MS; Miele M Brain Res; 1997 Jan; 745(1-2):173-82. PubMed ID: 9037407 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration. Piepponen TP; Mikkola JA; Ruotsalainen M; Jonker D; Ahtee L Br J Pharmacol; 1999 May; 127(1):268-74. PubMed ID: 10369482 [TBL] [Abstract][Full Text] [Related]
9. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. Airavaara M; Mijatovic J; Vihavainen T; Piepponen TP; Saarma M; Ahtee L Synapse; 2006 May; 59(6):321-9. PubMed ID: 16437537 [TBL] [Abstract][Full Text] [Related]
10. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Funada M; Suzuki T; Narita M; Misawa M; Nagase H Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722 [TBL] [Abstract][Full Text] [Related]
11. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats. Di Giannuario A; Pieretti S; Catalani A; Loizzo A Neurosci Lett; 1999 Sep; 272(3):183-6. PubMed ID: 10505611 [TBL] [Abstract][Full Text] [Related]
12. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal. Salminen O; Seppä T; Gäddnäs H; Ahtee L J Neurosci; 1999 Sep; 19(18):8145-51. PubMed ID: 10479714 [TBL] [Abstract][Full Text] [Related]
13. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
14. Withdrawal from repeated morphine sensitizes mice to the striatal dopamine release enhancing effect of acute morphine. Airio J; Attila M; Leikola-Pelho T; Ahtee L Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov; 350(5):548-54. PubMed ID: 7870194 [TBL] [Abstract][Full Text] [Related]
15. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats. Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568 [TBL] [Abstract][Full Text] [Related]
16. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats. Invernizzi R; Pozzi L; Samanin R Neuropharmacology; 1991 Jun; 30(6):575-8. PubMed ID: 1922681 [TBL] [Abstract][Full Text] [Related]
17. Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats. Di Giannuario A; Pieretti S Peptides; 2000 Jul; 21(7):1125-30. PubMed ID: 10998547 [TBL] [Abstract][Full Text] [Related]
18. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. Devine DP; Leone P; Pocock D; Wise RA J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399 [TBL] [Abstract][Full Text] [Related]
19. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat. Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Mura MA; De Natale G; Miele E; Miele M Brain Res; 1996 Jun; 723(1-2):154-61. PubMed ID: 8813393 [TBL] [Abstract][Full Text] [Related]